Eun Seung Lee

Title: Innovations in Drug Delivery by Eun Seung Lee

Introduction

Eun Seung Lee is an innovative inventor based in Salt Lake City, UT (US). He has made significant contributions to the field of drug delivery systems, particularly through his research on pH-sensitive polymeric micelles. His work focuses on enhancing the efficacy of cancer treatments, especially for tumors that exhibit multidrug resistance.

Latest Patents

Eun Seung Lee holds 1 patent for his invention titled "pH-sensitive polymeric micelles for drug delivery." This patent describes mixed micelles that consist of poly(L-histidine)-poly(ethylene glycol) block copolymer and poly(L-lactic acid)-poly(ethylene glycol) block copolymer. These micelles act as pH-sensitive drug carriers that release their payload in acidic microenvironments, such as those found in solid tumors, while remaining stable in the bloodstream. The ability to attach targeting ligands, such as folate, enhances the delivery of drugs into cancer cells, making this invention particularly valuable for cancer treatment.

Career Highlights

Eun Seung Lee has dedicated his career to advancing drug delivery technologies. His innovative approach to using pH-sensitive materials has opened new avenues for effective cancer therapies. His research not only addresses the challenges of drug resistance but also aims to improve patient outcomes through targeted treatment strategies.

Collaborations

Eun Seung Lee has collaborated with notable colleagues, including You Han Bae and Kun Na. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise in the field of drug delivery.

Conclusion

Eun Seung Lee's contributions to the development of pH-sensitive polymeric micelles represent a significant advancement in drug delivery systems. His innovative work has the potential to improve cancer treatment outcomes and offers hope for patients facing multidrug-resistant cancers.